AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 217 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $142,000 | +18.3% | 13,601 | +7.2% | 0.01% | +25.0% |
| Q1 2022 | $120,000 | -6.2% | 12,685 | +14.9% | 0.00% | 0.0% |
| Q4 2021 | $128,000 | -24.7% | 11,039 | -38.1% | 0.00% | -33.3% |
| Q3 2021 | $170,000 | +209.1% | 17,839 | +210.5% | 0.01% | +200.0% |
| Q2 2021 | $55,000 | +816.7% | 5,745 | +2264.2% | 0.00% | – |
| Q4 2020 | $6,000 | -53.8% | 243 | -82.3% | 0.00% | -100.0% |
| Q1 2020 | $13,000 | – | 1,370 | +2944.4% | 0.01% | – |
| Q4 2019 | $0 | -100.0% | 45 | -97.1% | 0.00% | -100.0% |
| Q3 2019 | $13,000 | -73.5% | 1,574 | -59.7% | 0.00% | -69.2% |
| Q2 2019 | $49,000 | +4800.0% | 3,906 | +6520.3% | 0.01% | – |
| Q4 2018 | $1,000 | -97.3% | 59 | -98.1% | 0.00% | -100.0% |
| Q3 2018 | $37,000 | +825.0% | 3,039 | +1110.8% | 0.01% | +1200.0% |
| Q2 2018 | $4,000 | – | 251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |